The Impact of Different Spinal Cord Stimulation Waveforms on Quality of Life in Patients With Chronic Pain (SCS-Quality)
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 120
- 试验地点
- 2
- 主要终点
- Non-inferiority VAS
研究概览
简要总结
Prospective, randomized, multicentre, parallel, controlled, and double-blind trial. It is a study with 2 groups with evaluation pre and post treatment with Spinal Cord Stimulation (SCS) implantation of patients with Failed Back Surgery Syndrome (FBSS). The study has been designed to assess primarily non-inferiority and secondarily superiority of SCS DTM therapy
详细描述
Over 18 years old patients, with leg with or without low back neuropathic pain (DN4 ≥4), previously undergoing low back surgery that, after an Evidence-Based (EB) medical therapy, can be eligible to SCS therapy following the Good Clinical Practice (GCP) guidelines will be implanted of two leads in the epidural thoracic level with at least two poles (Medtronic Vectris) covering the T9-T10 interspace and, if the trial is positive, a Medtronic Intellis Internal Pulse Generators (IPG) will be implanted.
The patients will be randomized to two groups to compare the improvement of pain control, the functional state and the quality of life of the patients by SCS Therapy across 12 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Care Provider, Investigator)
盲法说明
The patient will not informed about the treatment arm, but the presence of paresthesia is a factor that break the masking.
The care provider and investigators will not know the treatment arm and only collect the information in the forms.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Leg with/without Low back pain with neuropathic characteristics (VAS ≥ 5 and DN4≥4) during at least 6 months before the screening consultation.
- •Stable medical therapy with Evidence Based Medicine (EBM) during at least one month before the screening
- •Ready and able to accomplish the procedures of the study and use the activity monitor and the medication diary.
- •Have 18 years old or older when the patient signs the informed consent
- •Pain kept during at least the last 6 months with VAS ≥ 6 and functional limitation due to the pain
- •Refractory to treatment (during at least 3 months), and/or
- •Intolerable adverse effects that avoid an optimum medical treatment
- •Previous lumbosacral surgery for treatment of the cause of his pain
- •Pain attributable to a low back pathology
排除标准
- •Pregnant or with planned pregnancy
- •Life expectancy <1 year.
- •Polyneuropathy.
- •Important Heart disease or peripheral vascular disease
- •Degenerative disease that can decrease the functional capacity
- •Alcoholism - Drug abuse
- •Active infection
- •Oncological active disease
- •Haematological disorder with increased bleeding risk
- •Patient unable to understand / follow the target of the study and the work flow
- •When trial period has finished, the negative clinical response will be considered an exclusion criterion. The treatment could be completed, and the data collected but the patient will be excluded of the Randomized Clinical Trial (RCT) and the data analysed separately.
结局指标
主要结局
Non-inferiority VAS
时间窗: 3, 6,12 months
Non-inferiority of SCS DTM therapy compared with low frequency SCS in change of quantitative measure of pain with Visual Analogue Scale (VAS, 0-10 points, no pain to the worst pain imaginable).
次要结局
- Correlation between VAS and functionality and quality of life scores(3, 6,12 months)
- Objective measure of activity parameters(3, 6,12 months)
- Qualitative measure of dream quality(3, 6,12 months)
- Medication consumption(3, 6,12 months)
- Observational parameters: quality of battery charge(3, 6,12 months)
- Scores/Questionnaires of disability: ODI(3, 6,12 months)
- Superiority VAS(3, 6,12 months)
- Observational parameters: ratio of adverse effects(3, 6,12 months)
- Changes in quality of life assessed by wrist activity monitor accelerometer(3, 6,12 months)
- Scores/Questionnaires of quality of life: SF-36(3, 6,12 months)
- Observational parameters: time of battery charge(3, 6,12 months)
- Scores/Questionnaires of quality of life: EQ-5D(3, 6,12 months)
- Changes in VAS assessed by wrist activity monitor accelerometer(3, 6,12 months)
研究者
Pablo López Pais
Principal Investigator
Hospital Clinico Universitario de Santiago